Liothyronine-13C6-1
Names
[ CAS No. ]:
1213431-76-5
[ Name ]:
Liothyronine-13C6-1
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
13C6C9H12I3NO4
[ Molecular Weight ]:
656.93
[ Appearance of Characters ]:
liquid
Safety Information
[ Symbol ]:
GHS02, GHS06, GHS08
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H225-H301 + H311 + H331-H370
[ Precautionary Statements ]:
P210-P260-P280-P301 + P310-P311
[ RIDADR ]:
UN1230 - class 3 - PG 2 - Methanol, solution
Articles
PLoS ONE 9(5) , e97882, (2014)
Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measu...
Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.Crit. Rev. Oncol. Hematol. , doi:10.1016/j.critrevonc.2014.04.004, (2014)
Arterial thromboembolic events (ATEs) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have emerged as a serious concern, we perform a meta-analysis of randomiz...
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.Strahlenther. Onkol. , (2014)
The purpose of this study was to analyze the mode of relapse patterns and survival of 209 patients with stage IVA and IVB nasopharyngeal carcinoma (NPC).A total of 209 patients who underwent magnetic ...